Evidence map›Paper›PMID 22695943›Full record

ArticleInsights into imaging2012

MRI of the lung (3/3)-current applications and future perspectives.

Jürgen Biederer, S Mirsadraee, M Beer, F Molinari, C Hintze, G Bauman, M Both, E J R Van Beek, J Wild, M Puderbach

2 registry-linked trialsAbstract read
In one paragraph

Article in Insights into imaging, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 83 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02629432 completednot on this mapstarted 2013, after this paper: background citation

Image-Based Structural and Functional Phenotyping of the COSYCONET Cohort Using MRI and CT (MR COPD)

Typeobservational_patient_registrySponsorUniversity Hospital HeidelbergRan2013 to 2016Enrolled602ConditionsChronic Obstructive Pulmonary Disease (COPD)
NCT03591562 completednot on this mapstarted 2017, after this paper: background citation

Imaging Disease Progression in COPD (MR-COPDII)

TypeobservationalSponsorUniversity Hospital HeidelbergRan2017 to 2024Enrolled252ConditionsChronic Obstructive Pulmonary Disease
3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. The use of chest magnetic resonance imaging in interstitial lung disease: a systematic review.European respiratory review : an official journal of the European Respiratory Society · 2018
    Pooled it
  4. Article
  5. Article
  6. Review
  7. Restricted Diffusion on Diffusion-Weighted MRI in a Cat With Orbital Lymphoma and Presumptive Pulmonary Lymphoma.Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. [Magnetic resonance imaging of the pediatric chest].Radiologie (Heidelberg, Germany) · 2025
    Review
  12. Review
  13. Review
  14. Article
  15. Neuromorphic chips for biomedical engineering.Mechanobiology in medicine · 2025
    Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jürgen BiedererDepartment of Diagnostic Radiology, University Hospital Schleswig-Holstein, Campus Kiel, Arnold-Heller-Straße. 3, Haus 23, 24105, Kiel, Germany, juergen.biederer@rad.uni-kiel.de.
S Mirsadraee
M Beer
F Molinari
C Hintze
G Bauman
M Both
E J R Van Beek
J Wild
M Puderbach

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMRI of the lung is recommended in a number of clinical indications. Having a non-radiation alternative is particularly attractive in children and young subjects, or pregnant women.

methodsProvided there is sufficient expertise, magnetic resonance imaging (MRI) may be considered as the preferential modality in specific clinical conditions such as cystic fibrosis and acute pulmonary embolism, since additional functional information on respiratory mechanics and regional lung perfusion is provided. In other cases, such as tumours and pneumonia in children, lung MRI may be considered an alternative or adjunct to other modalities with at least similar diagnostic value.

resultsIn interstitial lung disease, the clinical utility of MRI remains to be proven, but it could provide additional information that will be beneficial in research, or at some stage in clinical practice. Customised protocols for chest imaging combine fast breath-hold acquisitions from a "buffet" of sequences. Having introduced details of imaging protocols in previous articles, the aim of this manuscript is to discuss the advantages and limitations of lung MRI in current clinical practice.

conclusionNew developments and future perspectives such as motion-compensated imaging with self-navigated sequences or fast Fourier decomposition MRI for non-contrast enhanced ventilation- and perfusion-weighted imaging of the lung are discussed. Main Messages • MRI evolves as a third lung imaging modality, combining morphological and functional information. • It may be considered first choice in cystic fibrosis and pulmonary embolism of young and pregnant patients. • In other cases (tumours, pneumonia in children), it is an alternative or adjunct to X-ray and CT. • In interstitial lung disease, it serves for research, but the clinical value remains to be proven. • New users are advised to make themselves familiar with the particular advantages and limitations.

Identifiers

PMID22695943
PMCPMC3481076

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.